Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
In trading on Wednesday, consumer discretionary shares fell by 0.9%.U.S. stocks traded lower this morning, with the Dow Jones index dipping more than 250 points on Wednesday.
美国股市在今早交易下跌，道琼斯指数周三下跌超过250点。
Following the market opening Wednesday, the Dow traded down 0.63% to 42,654.26 while the NASDAQ fell 0.47% to 18,486.46. The S&P 500 also fell, dropping, 0.33% to 5,831.63.
周三开盘后，道琼斯指数下跌0.63%，至42,654.26点，纳斯达克指数下跌0.47%，至18,486.46点。标普500指数也下跌0.33%，至5,831.63点。
Leading and Lagging Sectors
Utilities shares rose by 0.5% on Wednesday.
领涨与跌幅最大的板块：
周三公用事业股上涨0.5%。
In trading on Wednesday, consumer discretionary shares fell by 0.9%.
周三消费者自由股下跌0.9%。
Top Headline
头条新闻：
Boeing Co (NYSE:BA) reported a loss for the third quarter on Wednesday.
波音公司（纽交所: BA）周三报告第三季度亏损。
The company posted a 1% year-over-year revenue decline to $17.854 billion in the third quarter of 2024, missing the consensus of $17.931 billion. Adjusted loss per share expanded to $10.44 from $3.62 in the same quarter of 2023, missing the consensus of $10.34.
该公司在2024年第三季度的营业收入同比下降1％，至178.54亿美元，低于179.31亿美元的共识。每股调整后亏损从2023年同季度的3.62美元扩大至10.44美元，低于10.34美元的共识。
Equities Trading UP
股票上涨：
- La Rosa Holdings Corp. (NASDAQ:LRHC) shares shot up 164% to $1.3300 after the company reported preliminary 9-moth revenue growth of 120% year over year.
- Shares of CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) got a boost, surging 90% to $0.2979. The company requested a panel hearing for November 5, 2024, and will be subject to a halt in the suspension or delisting decision until then.
- Virax Biolabs Group Limited (NASDAQ:VRAX) shares were also up, gaining 87% to $3.1197 after the company announced a distribution agreement with Europa Biosite to commercialize the ImmuneSelect research-use portfolio in the United Kingdom and Ireland.
- La Rosa控股有限公司（纳斯达克：LRHC）股票价格飙升164%，至1.3300美元，公司报告显示，年度营业收入增长120%。
- cns pharmaceuticals股票（纳斯达克：CNSP）获得提振，涨幅90%，至0.2979美元。公司要求11月5日进行专家听证会，并将在那之前暂停或停止摘牌决定。
- Virax Biolabs集团有限公司（纳斯达克：VRAX）股价也上涨，涨幅87%，至3.1197美元，公司宣布与Europa Biosite达成分销协议，以在英国和爱尔兰商业化ImmuneSelect研究用产品组合。
Equities Trading DOWN
股票下跌：
- Alto Neuroscience, Inc. (NYSE:ANRO) shares dropped 62% to $5.53 after the company announced topline results from a Phase 2b trial evaluating ALTO-100 as a treatment for major depressed disorder did not meet its primary endpoint.
- Shares of Ensysce Biosciences, Inc. (NASDAQ:ENSC) were down 26% to $0.3960.
- Aptevo Therapeutics Inc. (NASDAQ:APVO) was down, falling 26% to $0.2616.
- Alto Neuroscience公司（纽交所：ANRO）股价下跌62%，至5.53美元，公司宣布从一项评估ALTO-100作为治疗重大抑郁症的第20亿阶段试验的最终数据未达到主要终点。
- Ensysce生物科技公司股票（纳斯达克：ENSC）下跌26%，至0.3960美元。
- Aptevo治疗学公司股票（纳斯达克：APVO）下跌26%，至0.2616美元。
Commodities
In commodity news, oil traded down 1.3% to $70.80 while gold traded down 0.5% at $2,747.40.
商品杂项
在商品新闻中，原油下跌1.3%，至70.80美元，黄金下跌0.5%，至2,747.40美元。
Silver traded down 2.5% to $34.180 on Wednesday, while copper fell 1.3% to $4.3240.
白银周三下跌2.5%，至34.180美元，而铜下跌1.3%，至4.3240美元。
Euro zone
欧元区：
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.2%, Germany's DAX fell 0.2% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 fell 0.5%.
欧洲股市今天大部分走低。欧元区的STOXX 600下跌0.2%，德国的DAX下跌0.2%，法国的CAC 40下跌0.5%。西班牙的IBEX 35指数上涨0.1%，而伦敦的FTSE 100下跌0.5%。
Asia Pacific Markets
亚太市场
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 0.80%, Hong Kong's Hang Seng Index gaining 1.27%, China's Shanghai Composite Index gaining 0.52% and India's BSE Sensex falling 0.17%.
周三亚洲市场收盘走势不一，日本的日经225指数下跌0.80%，香港的恒生指数上涨1.27%，中国的上海综合指数上涨0.52%，印度的BSE Sensex指数下跌0.17%。
Singapore's annual inflation rate eased to 2.0% in September versus 2.2% in the previous month.
新加坡9月份的年通胀率为2.0%，而上个月为2.2%。
Economics
经济学
U.S. mortgage applications declined by 6.7% from the previous week during the third week of October, following a 17% dip in the earlier period.
美国在十月第三周的抵押贷款申请量较上周下降了6.7%，此前期间下降了17%。
Now Read This:
现在阅读这个：
- Top 2 Energy Stocks That May Implode This Quarter
- 可能在本季度崩盘的前两大能源股
